Evaluation of hGM-CSF/hTNFα surface-modified prostate cancer therapeutic vaccine in the huPBL-SCID chimeric mouse model

To validate its efficacy in the context of the human immune system, a novel therapeutic vaccine of hGM-CSF/hTNFα surface-modified PC-3 cells against human prostate cancer was evaluated in the human peripheral blood lymphocytes-severe combined immunodeficiency (huPBL-SCID) chimeric mouse model. The h...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Hematol Oncol
Glavni autori: Lai, Shouhua, Huang, Zhiyong, Guo, Yunting, Cui, Yunqin, Wang, Lei, Ren, Weifeng, Ying, Furong, Gao, Hui, He, Lingxia, Zhou, Tieli, Jiang, Jiegen, Gao, Jimin
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Letter to the Editor
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4490636/
https://ncbi.nlm.nih.gov/pubmed/26108270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-015-0175-8
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items